JP2024525721A5 - - Google Patents
Info
- Publication number
- JP2024525721A5 JP2024525721A5 JP2024501712A JP2024501712A JP2024525721A5 JP 2024525721 A5 JP2024525721 A5 JP 2024525721A5 JP 2024501712 A JP2024501712 A JP 2024501712A JP 2024501712 A JP2024501712 A JP 2024501712A JP 2024525721 A5 JP2024525721 A5 JP 2024525721A5
- Authority
- JP
- Japan
- Prior art keywords
- expression construct
- vector
- construct according
- sequence number
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163221883P | 2021-07-14 | 2021-07-14 | |
| US63/221,883 | 2021-07-14 | ||
| PCT/IB2022/056458 WO2023285987A1 (en) | 2021-07-14 | 2022-07-13 | Retgc gene therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024525721A JP2024525721A (ja) | 2024-07-12 |
| JP2024525721A5 true JP2024525721A5 (enExample) | 2025-07-22 |
Family
ID=82932504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024501712A Pending JP2024525721A (ja) | 2021-07-14 | 2022-07-13 | Ｒｅｔｇｃ遺伝子治療 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250002936A1 (enExample) |
| EP (1) | EP4370695A1 (enExample) |
| JP (1) | JP2024525721A (enExample) |
| KR (1) | KR20240055728A (enExample) |
| CN (1) | CN117980489A (enExample) |
| AU (1) | AU2022310166A1 (enExample) |
| CA (1) | CA3225084A1 (enExample) |
| IL (1) | IL310017A (enExample) |
| MX (1) | MX2024000747A (enExample) |
| WO (1) | WO2023285987A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026150224A1 (en) | 2024-12-30 | 2026-07-16 | MeiraGTx Ocular UK Limited | Modified adeno-associated virus (aav) viral capsid proteins and methods of use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4345297A1 (de) | 1993-11-11 | 1995-09-28 | Nsm Ag | Geldspielgerät |
| US5856152A (en) | 1994-10-28 | 1999-01-05 | The Trustees Of The University Of Pennsylvania | Hybrid adenovirus-AAV vector and methods of use therefor |
| CA2346262A1 (en) | 1998-09-17 | 2000-03-23 | University Of Florida | Methods for treatment of degenerative retinal diseases |
| HUE041571T2 (hu) * | 2010-04-23 | 2019-05-28 | Univ Florida | RAAV-guanilát-cikláz-készítmények és ejárások 1-es típusú Leber-féle veleszületett vakság (LCA1) kezelésére |
| MA44546B1 (fr) | 2016-06-15 | 2021-03-31 | Univ California | Virus adéno-associés variants et procédés d'utilisation |
| CA3084733A1 (en) * | 2017-12-14 | 2019-06-20 | Crispr Therapeutics Ag | Materials and methods for treatment of autosomal dominant cone-rod dystrophy |
-
2022
- 2022-07-13 EP EP22754918.5A patent/EP4370695A1/en active Pending
- 2022-07-13 AU AU2022310166A patent/AU2022310166A1/en active Pending
- 2022-07-13 US US18/578,626 patent/US20250002936A1/en active Pending
- 2022-07-13 IL IL310017A patent/IL310017A/en unknown
- 2022-07-13 KR KR1020247004961A patent/KR20240055728A/ko active Pending
- 2022-07-13 WO PCT/IB2022/056458 patent/WO2023285987A1/en not_active Ceased
- 2022-07-13 JP JP2024501712A patent/JP2024525721A/ja active Pending
- 2022-07-13 CN CN202280059234.6A patent/CN117980489A/zh active Pending
- 2022-07-13 CA CA3225084A patent/CA3225084A1/en active Pending
- 2022-07-13 MX MX2024000747A patent/MX2024000747A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220331409A1 (en) | Factor ix gene therapy | |
| CN104937100B (zh) | Aav 变体 | |
| ES3052719T3 (en) | Polynucleotides and vectors for the expression of transgenes | |
| EP3452495B1 (en) | Adeno-associated virus polynucleotides, polypeptides and virions | |
| JP2023123765A5 (enExample) | ||
| JP2022530656A5 (enExample) | ||
| JP2022530633A5 (enExample) | ||
| CN115298316A (zh) | 用于制备腺相关病毒载体的方法 | |
| US20040087028A1 (en) | Ecdysone-inducible adeno-associated virus expression vectors | |
| CA3097392A1 (en) | Gene therapy for diseases caused by unbalanced nucleotide pools including mitochondrial dna depletion syndromes | |
| WO2017192750A1 (en) | Recombinant adeno-associated viral vectors | |
| JP2018515096A (ja) | 神経成長因子シグナルペプチド及び副甲状腺ホルモンを含むａａｖ分離株及び融合タンパク質 | |
| RU2020137429A (ru) | Лечение пигментного ретинита | |
| JP2024523707A5 (enExample) | ||
| JP2023537625A5 (enExample) | ||
| US12359219B2 (en) | Transgene cassettes designed to express a human MECP2 gene | |
| RU2018125468A (ru) | Генная терапия офтальмологических нарушений | |
| JP2017529395A5 (enExample) | ||
| JP2020527335A5 (enExample) | ||
| JP2024513907A5 (enExample) | ||
| CA3108324A1 (en) | Gene therapy methods to control organ function | |
| JP2023550581A5 (enExample) | ||
| JP2023542241A5 (enExample) | ||
| JP2024525742A5 (enExample) | ||
| JP2022552892A5 (enExample) |